Article mayhem
   
Nav Menu
select
home
select
Sign up
select
Login
select
Submit Articles
select
Submission Guidelines
select
Top Articles
select
Link Directory
select
About Us
select
Contact Us
select
Privacy Policy
select
RSS Feeds
 
Categories

Accessories
Arts
Business
Cars and Trucks
CGI
Coding Sites
Computers
Cooking
Crafts
Current Affairs
Databases
Entertainment
Film
Finances
Gardening
Healthy Living
Holidays
Home
Internet
Medical
Men Only
Motorcyles
Our Pets
Outdoors
Relationships
Religion
Self Improvement
Sports
Staying Fit
Technology
Travel
Web Design
Weddings
Women Only
Writing
 
Stats
Total Articles: 519629
Total Authors: 142199
Total Downloads: 20359322


Newest Member
Patrick Winter

 


   

CD31 antibody may help to develop novel cardiovascular therapies


CD31, also known as PECAM1 (platelet endothelial cell adhesion molecule 1), encodes a type I integral membrane protein and member of the immunoglobulin receptor superfamily. The CD31 antibody is widely used as an endothelial marker.

CD31 is expressed on a number of cell types, including macrophages, lymphocytes and endothelial cells, and is specifically concentrated at endothelial junctions. CD31 antibody studies have shown PECAM1 is also expressed in a number of soft tissue, vascular and endothelial tumours; the CD31 antibody database is a useful source of endothelial markers when studying angiogenesis in connection with tumour recurrence.

CD31 is expressed on the membranes of some endothelial blood-vessel cells. Recently, cardiologist Young-sup Yoon, of Emory University, published a CD31 antibody study suggesting CD31 may be significant in developing new cardiovascular therapies.

In Yoon’s study, the CD31 antibody was used in both donated human blood and mouse bone marrow cells to detect and isolate CD31(+) endothelial cells. Using an in vivo mouse model of PVD (peripheral vascular disease), it was seen that CD31(+) cells secreted hormones which supported the growth of new vasculature, enabling continued circulation through the legs. In vitro, CD31(+) cells were shown to mimic the growth of new blood vessels by developing tubular structures.

It was suggested that harvesting CD31-positive cells had several advantages over stem cells. They can be grown quickly, and do not require large volumes of patient blood or bone marrow. It is hoped the research may pave the way for novel cardiovascular disease treatments in the future.

We at Novus Biologicals have an extensive antibody database to support vascular research, to which we recently added a new CD31 antibody.




Author Resource:- The Article is written by www.novusbio.com providing Antibody Catalogue and Antibody Database. Visit http://www.novusbio.com for more information on www.novusbio.com Products and Services___________________________Copyright information This article is free for reproduction but must be reproduced in its entirety, including live links and this copyright statement must be included. Visit www.novusbio.com for more services!

[Valid RSS feed]  Category Rss Feed - http://www.articlemayhem.com/rss.php?rss=191
By : Gen Federico    19 or more times read
Submitted 2011-08-29 00:36:17
Article From Article Mayhem

ezine ready view Ezine ready view

Related Articles

 
 


[Valid RSS feed]